HIF2α is a direct regulator of neutrophil motility.


Journal

Blood
ISSN: 1528-0020
Titre abrégé: Blood
Pays: United States
ID NLM: 7603509

Informations de publication

Date de publication:
17 06 2021
Historique:
received: 05 06 2020
accepted: 24 01 2021
pubmed: 24 2 2021
medline: 15 12 2021
entrez: 23 2 2021
Statut: ppublish

Résumé

Orchestrated recruitment of neutrophils to inflamed tissue is essential during the initiation of inflammation. Inflamed areas are usually hypoxic, and adaptation to reduced oxygen pressure is typically mediated by hypoxia pathway proteins. However, it remains unclear how these factors influence the migration of neutrophils to and at the site of inflammation during their transmigration through the blood-endothelial cell barrier, as well as their motility in the interstitial space. Here, we reveal that activation of hypoxia-inducible factor 2 (HIF2α) as a result of a deficiency in HIF prolyl hydroxylase domain protein 2 (PHD2) boosts neutrophil migration specifically through highly confined microenvironments. In vivo, the increased migratory capacity of PHD2-deficient neutrophils resulted in massive tissue accumulation in models of acute local inflammation. Using systematic RNA sequencing analyses and mechanistic approaches, we identified RhoA, a cytoskeleton organizer, as the central downstream factor that mediates HIF2α-dependent neutrophil motility. Thus, we propose that the novel PHD2-HIF2α-RhoA axis is vital to the initial stages of inflammation because it promotes neutrophil movement through highly confined tissue landscapes.

Identifiants

pubmed: 33619535
pii: S0006-4971(21)00419-5
doi: 10.1182/blood.2020007505
doi:

Substances chimiques

Basic Helix-Loop-Helix Transcription Factors 0
endothelial PAS domain-containing protein 1 1B37H0967P

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3416-3427

Commentaires et corrections

Type : CommentIn

Informations de copyright

© 2021 by The American Society of Hematology.

Auteurs

Sundary Sormendi (S)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.

Mathieu Deygas (M)

Institut Curie, Paris Sciences et Lettres (PSL) Research University, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 144, Paris, France.
Institut Pierre-Gilles de Gennes, PSL Research University, Paris, France.

Anupam Sinha (A)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.

Mathilde Bernard (M)

Institut Curie, Paris Sciences et Lettres (PSL) Research University, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 144, Paris, France.
Institut Pierre-Gilles de Gennes, PSL Research University, Paris, France.

Anja Krüger (A)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.

Ioannis Kourtzelis (I)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.

Gregoire Le Lay (G)

Institut Curie, Paris Sciences et Lettres (PSL) Research University, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 144, Paris, France.
Institut Pierre-Gilles de Gennes, PSL Research University, Paris, France.

Pablo J Sáez (PJ)

Institut Curie, Paris Sciences et Lettres (PSL) Research University, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 144, Paris, France.
Institut Pierre-Gilles de Gennes, PSL Research University, Paris, France.

Michael Gerlach (M)

Core Facility Cellular Imaging, Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Kristin Franke (K)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.

Ana Meneses (A)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.

Martin Kräter (M)

Biotechnology Center, Center for Molecular and Cellular Bioengineering, and.

Alessandra Palladini (A)

Paul Langerhans Institute Dresden, Helmholtz Zentrum Munich, University Hospital-Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; and.
German Center for Diabetes Research, Neuherberg, Germany.

Jochen Guck (J)

Biotechnology Center, Center for Molecular and Cellular Bioengineering, and.

Ünal Coskun (Ü)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.
Paul Langerhans Institute Dresden, Helmholtz Zentrum Munich, University Hospital-Faculty of Medicine Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany; and.
German Center for Diabetes Research, Neuherberg, Germany.

Triantafyllos Chavakis (T)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.

Pablo Vargas (P)

Institut Curie, Paris Sciences et Lettres (PSL) Research University, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 144, Paris, France.
Institut Pierre-Gilles de Gennes, PSL Research University, Paris, France.

Ben Wielockx (B)

Institute of Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
C-Reactive Protein Humans Biomarkers Inflammation
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation

Classifications MeSH